EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Efficacy of the Cordia myxa Syrup (Sepestan) on Reduction of Severity and Duration of Diarrhea in Pediatrics with Gastroenteritis: A Randomized Placebo-Controlled Trial

Neda Mohtasham, Eskandar Moghimi Pour, Amanollah Zarei-Ahmady, Ali Rajabian, Amal Saki Malehi, Mana Hafezi Birgani

Journal of Comprehensive Pediatrics · 2025-12-15 · 17 (1)

DOI: 10.5812/jcp-166340 ↗

At a glance

Journal article in Journal of Comprehensive Pediatrics, published online on 2025-12-15. Written by Neda Mohtasham and 5 co-authors. Cited 1 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY 4.0).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Diarrhea is one of the most common gastrointestinal problems in children, potentially leading to dehydration, weakness, and hospitalization. Various treatments have been proposed to reduce the severity and duration of diarrhea; however, the need for more effective approaches remains.

Objectives

This study aimed to evaluate the efficacy of Cordia myxa syrup, known as “Sepestan,” in reducing the severity and duration of diarrhea in patients with gastroenteritis.

Methods

This double-blinded, randomized controlled clinical trial was conducted using the simple randomization method. A total of 140 patients with gastroenteritis aged 1 - 8 years, referred to Abuzar Hospital in Ahvaz, Iran in 2024, were enrolled. Patients with gastroenteritis whose symptoms had occurred within less than 24 hours, with no prior medication use, no severe dehydration, and no abnormal stool findings were included. These eligible patients were divided into two equal groups: The intervention group (receiving C. myxa syrup) at a dose of 20 mg/kg/day, and the control group (receiving placebo). Data on age, sex, diarrhea severity and frequency, stool volume and consistency, duration of diarrhea, and other clinical symptoms were recorded and analyzed on days 1, 2, 3, and 7. Both the patients (and their parents) and the researchers were blinded to the assigned treatment groups.

Results

The mean age of participants was 27.53 ± 18.81 months. The C. myxa group demonstrated a statistically significant reduction in diarrhea duration (mean 3.91 days vs. 4.71 days in the control group, P = 0.000) and diarrhea frequency at 72 hours (P = 0.023). Stool volume analysis indicated a remarkable treatment effect (F = 49.929, P < 0.001), and stool consistency analysis also showed considerable improvement in the intervention group (F = 39.803, P < 0.001). Age had no significant effect in any statistical model, such as stool volume (P = 0.892) or stool consistency (P = 0.961).

Conclusions

Our findings suggest that C. myxa syrup can significantly reduce both the duration and severity of diarrhea. This syrup may serve as an effective therapeutic option for patients with gastroenteritis. Limitations of this study were the single-center nature of the study, the short follow-up period, and restriction to a specific age group. Further multicenter studies with longer follow-up periods are recommended to confirm its effectiveness.

Cite

APA

Mohtasham, N., Pour, E. M., Zarei-Ahmady, A., Rajabian, A., Malehi, A. S., & Birgani, M. H. (2025). Efficacy of the Cordia myxa Syrup (Sepestan) on Reduction of Severity and Duration of Diarrhea in Pediatrics with Gastroenteritis: A Randomized Placebo-Controlled Trial. Journal of Comprehensive Pediatrics, 17(1). https://doi.org/10.5812/jcp-166340

Vancouver

Mohtasham N, Pour EM, Zarei-Ahmady A, Rajabian A, Malehi AS, Birgani MH. Efficacy of the Cordia myxa Syrup (Sepestan) on Reduction of Severity and Duration of Diarrhea in Pediatrics with Gastroenteritis: A Randomized Placebo-Controlled Trial. Journal of Comprehensive Pediatrics. 2025;17(1). doi:10.5812/jcp-166340

BibTeX
@article{Mohtasham2025,
  author = {Mohtasham, Neda and Pour, Eskandar Moghimi and Zarei-Ahmady, Amanollah and Rajabian, Ali and Malehi, Amal Saki and Birgani, Mana Hafezi},
  title = {Efficacy of the Cordia myxa Syrup (Sepestan) on Reduction of Severity and Duration of Diarrhea in Pediatrics with Gastroenteritis: A Randomized Placebo-Controlled Trial},
  journal = {Journal of Comprehensive Pediatrics},
  year = {2025},
  volume = {17},
  number = {1},
  doi = {10.5812/jcp-166340}
}
Start for free →